Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
peripheral neuropathy in feet and leg.; This serious case was reported by a consumer via interactive digital media and described the occurrence of peripheral neuropathy in a adult female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced peripheral neuropathy (Verbatim: peripheral neuropathy in feet and leg.) (serious criteria disability and GSK medically significant). The outcome of the peripheral neuropathy was not resolved. The reporter considered the peripheral neuropathy to be related to Shingles vaccine. The company considered the peripheral neuropathy to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date: 26-MAR-2025 This case was reported by a patient via interactive digital media. The patient wished she would have never taken the Shingles vaccine. She reported that she had been dealing with the effects for several years. Almost like having inner shingles. The patient experienced burning tingling and loss of feeling in feet and legs. She continued to have peripheral neuropathy in feet and legs. She stated that the physician just treated symptoms with every drug imaginable.; Sender's Comments: Neuropathy peripheral is an unlisted event which is considered unrelated to GSK vaccine Shingles vaccine